Immunological Reviews,
Journal Year:
2022,
Volume and Issue:
311(1), P. 39 - 49
Published: July 31, 2022
Summary
The
blood–brain
barrier
(BBB)
is
a
selectively
permeable
separating
the
periphery
from
central
nervous
system
(CNS).
BBB
restricts
flow
of
most
material
into
and
out
CNS,
including
many
drugs
that
could
be
used
as
potent
therapies.
permeability
modulated
by
several
cells
are
collectively
called
neurovascular
unit
(NVU).
NVU
consists
specialized
CNS
endothelial
(ECs),
pericytes,
astrocytes,
microglia,
neurons.
ECs
maintain
complex
“seal”
via
tight
junctions,
forming
BBB;
breakdown
these
junctions
leads
to
disruption.
Pericytes
control
vascular
within
capillaries
help
basal
lamina.
Astrocytes
much
has
moved
beyond
EC
layer
can
form
secondary
under
inflammatory
conditions.
Microglia
survey
border
for
noxious
material.
Neuronal
activity
also
plays
role
in
maintenance
BBB.
Since
neurons
all
able
modulate
BBB,
understating
contributions
each
member
will
potentially
uncover
novel
effective
methods
delivery
neurotherapies
CNS.
Brain Research Bulletin,
Journal Year:
2025,
Volume and Issue:
221, P. 111191 - 111191
Published: Jan. 7, 2025
Major
depressive
disorder
(MDD)
is
a
common
mental
with
chronic
tendencies
that
seriously
affect
regular
work,
life,
and
study.
However,
its
exact
pathogenesis
remains
unclear.
Patients
MDD
experience
systemic
localized
impairments
in
glucose
metabolism
throughout
the
disease
course,
disrupting
various
processes
such
as
uptake,
glycoprotein
transport,
glycolysis,
tricarboxylic
acid
cycle
(TCA),
oxidative
phosphorylation
(OXPHOS).
These
may
result
from
mechanisms
including
insulin
resistance,
hyperglycemia-induced
damage,
stress,
astrocyte
abnormalities,
mitochondrial
dysfunction,
leading
to
insufficient
energy
supply,
altered
synaptic
plasticity,
neuronal
cell
death,
functional
structural
damage
reward
networks.
mechanical
changes
contribute
of
severely
interfere
prognosis.
Herein,
we
summarized
impairment
pathophysiological
patients
MDD.
In
addition,
briefly
discussed
potential
pharmacological
interventions
for
alleviate
MDD,
glucagon-like
peptide-1
receptor
agonists,
metformin,
topical
insulin,
liraglutide,
pioglitazone,
encourage
development
new
therapeutics.
Immunological Reviews,
Journal Year:
2022,
Volume and Issue:
311(1), P. 39 - 49
Published: July 31, 2022
Summary
The
blood–brain
barrier
(BBB)
is
a
selectively
permeable
separating
the
periphery
from
central
nervous
system
(CNS).
BBB
restricts
flow
of
most
material
into
and
out
CNS,
including
many
drugs
that
could
be
used
as
potent
therapies.
permeability
modulated
by
several
cells
are
collectively
called
neurovascular
unit
(NVU).
NVU
consists
specialized
CNS
endothelial
(ECs),
pericytes,
astrocytes,
microglia,
neurons.
ECs
maintain
complex
“seal”
via
tight
junctions,
forming
BBB;
breakdown
these
junctions
leads
to
disruption.
Pericytes
control
vascular
within
capillaries
help
basal
lamina.
Astrocytes
much
has
moved
beyond
EC
layer
can
form
secondary
under
inflammatory
conditions.
Microglia
survey
border
for
noxious
material.
Neuronal
activity
also
plays
role
in
maintenance
BBB.
Since
neurons
all
able
modulate
BBB,
understating
contributions
each
member
will
potentially
uncover
novel
effective
methods
delivery
neurotherapies
CNS.